Leukemia  >>  dociparstat sodium (CX-01)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dociparstat sodium (CX-01) / Cantex Pharma, Chimerix
NCT02873338: Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Completed
2
75
US
Dociparstat sodium, 2-O, 3-O desulfated heparin, ODSH, PGX-100, CX-01, Dociparstat, Idarubicin, Idamycin, Cytarabine
Chimerix
Acute Myeloid Leukemia
06/19
06/19

Download Options